Biopharmaceuticals
Biopharmaceutical companies are pressured by increasingly sophisticated and price-sensitive customers, regulatory regimes that are more conservative than before, reduced research and development (R&D) productivity, and increased intensity in competition. Executives seeking competitive advantage, therefore, are asking a number of questions:Most popular related searches
- How can we sustain growth in the face of patent expirations, a dearth of blockbusters, pressures on price and reimbursement, increasing competition, and lower-cost substitutes?
- What organizational changes should we make to thrive in the new environment?
- How can we reduce our cost base without sacrificing critical capabilities?
- How should we transform our commercial organizations in light of quickly evolving conditions?